We are live on ! Find out more
CA

Continental Advisors Portfolio holdings

AUM $196M
1-Year Est. Return 24.19%
This Fund
S&P 500
This Quarter Est. Return
-1.24%
1 Year Est. Return
+24.19%
3 Year Est. Return
+67.62%
5 Year Est. Return
+60.86%
10 Year Est. Return
+208.23%
AUM
$236M
AUM Growth
+$18.7M
Cap. Flow
+$21.5M
Cap. Flow %
9.13%
Top 10 Hldgs %
39.76%
Holding
67
New
10
Increased
19
Reduced
22
Closed
3

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.87M
2
GILD icon
Gilead Sciences
GILD
+$1.69M
3
THC icon
Tenet Healthcare
THC
+$1.18M
4
WFC icon
Wells Fargo
WFC
+$1.02M
5
KR icon
Kroger
KR
+$924K

Sector Composition

Rank Sector Weight
1 Financials 22.12%
2 Healthcare 18.51%
3 Consumer Staples 2.93%
4 Industrials 2.36%
5 Consumer Discretionary 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROV icon
51
Provident Financial
PROV
$108M
$1.33M 0.56%
78,676
THC icon
52
Tenet Healthcare
THC
$20.1B
$1.3M 0.55%
19,570
-16,671
-46% -$1.18M
MRK icon
53
Merck
MRK
$324B
$1.28M 0.54%
17,031
-3,100
-15% -$236K
AMLP icon
54
CALL
Alerian MLP ETF
AMLP
$13B
$1M 0.42%
+30,000
New +$1M
MYGN icon
55
Myriad Genetics
MYGN
$530M
$804K 0.34%
24,892
-4,500
-15% -$149K
CAH icon
56
CALL
Cardinal Health
CAH
$53.4B
$791K 0.34%
+16,000
New +$868K
FBNC icon
57
First Bancorp
FBNC
$2.6B
$733K 0.31%
17,031
RVSB icon
58
Riverview Bancorp
RVSB
$107M
$729K 0.31%
100,209
BHC icon
59
Bausch Health
BHC
$1.65B
$641K 0.27%
23,000
JNJ icon
60
Johnson & Johnson
JNJ
$635B
$620K 0.26%
3,839
-1,664
-30% -$284K
GDX icon
61
CALL
VanEck Gold Miners ETF
GDX
$23B
$589K 0.25%
20,000
LKFT
62
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$526K 0.22%
+10,000
New +$594K
BSX icon
63
Boston Scientific
BSX
$65.8B
$462K 0.2%
10,642
-1,110
-9% -$49.1K
AMZN icon
64
PUT
Amazon
AMZN
$2.5T
$329K 0.14%
+2,000
New +$345K
BLUE
65
DELISTED
bluebird bio
BLUE
-1,197
Closed -$496K
IBB icon
66
PUT
iShares Biotechnology ETF
IBB
$9.31B
-5,100
Closed -$835K
SC
67
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-22,940
Closed -$833K

Similar funds

Continental Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Continental Advisors held 67 positions worth $236M, up 8.6% from $217M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Continental Advisors deployed $21.5M of net new capital in Q3 2021, opening 10 new positions and adding to 19 existing holdings. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 10,000 shares worth $526K.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Pfizer, an estimated $1.87M trimmed.

  • Continental Advisors's largest Q3 2021 buy was Lakefront Biotherapeutics American Depositary Shares: 10,000 shares worth $526K.
  • Continental Advisors added most to Cannae Holdings in Q3 2021, an estimated $2.77M increase.
  • Continental Advisors's biggest Q3 2021 reduction was Pfizer, cutting an estimated $1.87M.
  • Continental Advisors fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q3 2021, selling an estimated $833K.
  • Continental Advisors's ten largest holdings make up 40% of its $236M portfolio in Q3 2021.
  • Continental Advisors opened 10 new positions and closed 3 in Q3 2021.
  • Continental Advisors's portfolio value rose 8.6% quarter-over-quarter to $236M.

Based on Continental Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.